![Report CIS - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights for 499$](/landing/img/reports/cis-medicaments-containing-insulin-but-not-antibiotics-market-analysis-forecast-size-trends-and-insights.webp)
CIS - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingCIS: Medicaments Containing Insulin Market 2024
Medicaments Containing Insulin Market Size in CIS
The CIS medicaments containing insulin market soared to $X in 2023, jumping by X% against the previous year. Over the period under review, consumption, however, saw a deep reduction. Over the period under review, the market hit record highs at $X in 2014; however, from 2015 to 2023, consumption stood at a somewhat lower figure.
Medicaments Containing Insulin Production in CIS
In value terms, medicaments containing insulin production fell modestly to $X in 2023 estimated in export price. Overall, production, however, continues to indicate a noticeable slump. The pace of growth was the most pronounced in 2019 with an increase of X,150% against the previous year. As a result, production reached the peak level of $X. From 2020 to 2023, production growth failed to regain momentum.
Medicaments Containing Insulin Exports
Exports in CIS
In 2023, overseas shipments of medicaments containing insulin but not antibiotics decreased by X% to X kg for the first time since 2019, thus ending a three-year rising trend. In general, exports continue to indicate a deep reduction. The most prominent rate of growth was recorded in 2022 when exports increased by X% against the previous year. The volume of export peaked at X kg in 2017; however, from 2018 to 2023, the exports failed to regain momentum.
In value terms, medicaments containing insulin exports reduced sharply to $X in 2023. Overall, exports saw a dramatic decrease. The most prominent rate of growth was recorded in 2022 when exports increased by X%. The level of export peaked at $X in 2017; however, from 2018 to 2023, the exports failed to regain momentum.
Exports by Country
Russia (X kg) represented roughly X% of total exports in 2023.
Russia was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics exports, with a CAGR of X% from 2015 to 2023. The shares of the largest exporters remained relatively stable throughout the analyzed period.
In value terms, Russia ($X) also remains the largest medicaments containing insulin supplier in the CIS.
From 2015 to 2023, the average annual growth rate of value in Russia stood at X%.
Export Prices by Country
In 2023, the export price in the CIS amounted to $X per ton, reducing by X% against the previous year. Over the period under review, the export price showed a abrupt descent. The pace of growth was the most pronounced in 2022 an increase of X%. Over the period under review, the export prices reached the maximum at $X,000 per ton in 2020; however, from 2021 to 2023, the export prices failed to regain momentum.
As there is only one major export destination, the average price level is determined by prices for Russia.
From 2015 to 2023, the rate of growth in terms of prices for Russia amounted to X% per year.
Medicaments Containing Insulin Imports
Imports in CIS
Medicaments containing insulin imports surged to X kg in 2023, growing by X% against the previous year's figure. Over the period under review, imports, however, saw a abrupt slump. The growth pace was the most rapid in 2014 when imports increased by X%. As a result, imports attained the peak of X tons. From 2015 to 2023, the growth of imports failed to regain momentum.
In value terms, medicaments containing insulin imports surged to $X in 2023. Overall, imports posted mild growth. The most prominent rate of growth was recorded in 2013 with an increase of X%. As a result, imports attained the peak of $X. From 2014 to 2023, the growth of imports remained at a somewhat lower figure.
Imports by Country
In 2023, Belarus (X kg) and Tajikistan (X kg) represented the largest importers of medicaments containing insulin but not antibiotics in the CIS, together reaching approx. X% of total imports. It was distantly followed by Russia (X kg), making up a X% share of total imports.
From 2012 to 2023, the most notable rate of growth in terms of purchases, amongst the main importing countries, was attained by Tajikistan (with a CAGR of X%), while imports for the other leaders experienced mixed trends in the imports figures.
In value terms, Russia ($X), Belarus ($X) and Tajikistan ($X) constituted the countries with the highest levels of imports in 2023.
Belarus, with a CAGR of X%, recorded the highest growth rate of the value of imports, in terms of the main importing countries over the period under review, while purchases for the other leaders experienced more modest paces of growth.
Import Prices by Country
In 2023, the import price in the CIS amounted to $X per ton, rising by X% against the previous year. Overall, the import price showed prominent growth. The most prominent rate of growth was recorded in 2013 when the import price increased by X%. Over the period under review, import prices hit record highs at $X,333 per ton in 2019; however, from 2020 to 2023, import prices failed to regain momentum.
There were significant differences in the average prices amongst the major importing countries. In 2023, amid the top importers, the country with the highest price was Russia ($X,571 per ton), while Tajikistan ($X per ton) was amongst the lowest.
From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Russia (X%), while the other leaders experienced more modest paces of growth.
Source: IndexBox Platform
This report provides an in-depth analysis of the medicaments containing insulin market in CIS. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale
Country coverage:
- Armenia
- Azerbaijan
- Belarus
- Kazakhstan
- Kyrgyzstan
- Moldova
- Russia
- Tajikistan
- Uzbekistan
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Production in CIS, split by region and country
- Trade (exports and imports) in CIS
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- CONSUMPTION BY COUNTRY
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
- PRODUCTION BY COUNTRY
8. IMPORTS
The Largest Importers on The Market and How They Succeed
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Exporters on The Market and How They Succeed
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
11. COUNTRY PROFILES
The Largest Markets And Their Profiles
This Chapter is Available Only for the Professional Edition PRO- Armenia
- Azerbaijan
- Belarus
- Kazakhstan
- Kyrgyzstan
- Moldova
- Russia
- Tajikistan
- Uzbekistan
-
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption, By Country, 2018–2023
- Production, In Physical Terms, By Country, 2012–2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Destination, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Origin, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Consumption, By Country, 2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Production, By Country, 2023
- Production, In Physical Terms, By Country, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, 2012–2023
Recommended reports
This report provides an in-depth analysis of the medicaments containing insulin market in Asia.
This report provides an in-depth analysis of the medicaments containing insulin market in the U.S..
This report provides an in-depth analysis of the medicaments containing insulin market in China.
This report provides an in-depth analysis of the medicaments containing insulin market in the EU.
This report provides an in-depth analysis of the global medicaments containing insulin market.